MTM Documentation Standards & Regulatory Compliance 5 — Questions and Answers
Question 1: A Medicare Part D MTM program must, at minimum, offer a CMR to eligible beneficiaries how frequently?
- Every 6 months
- Annually (Correct answer)
- Every 2 years
- Quarterly
Correct answer: Annually
CMS requires Part D MTM programs to offer at least one CMR annually to all eligible beneficiaries.
Question 2: When documenting a prescriber communication regarding a drug therapy problem, which format is considered most legally defensible?
- A verbal-only communication with no written record
- A written or electronic record including date, time, content of communication, and prescriber response (Correct answer)
- A notation in the patient's social media health profile
- A verbal report to the patient asking them to relay the message to their doctor
Correct answer: A written or electronic record including date, time, content of communication, and prescriber response
A contemporaneous written record of the communication, including the prescriber's response, creates an auditable trail that supports legal defensibility and continuity of care.
Question 3: Which regulatory body has primary oversight authority for enforcing HIPAA Privacy Rule compliance in MTM documentation?
- The Drug Enforcement Administration (DEA)
- The Office for Civil Rights (OCR) within the Department of Health and Human Services (Correct answer)
- The Food and Drug Administration (FDA)
- The Centers for Medicare & Medicaid Services (CMS) Office of Inspector General
Correct answer: The Office for Civil Rights (OCR) within the Department of Health and Human Services
The HHS Office for Civil Rights (OCR) is the primary enforcer of the HIPAA Privacy and Security Rules, including for MTM-related PHI documentation.
Question 4: An MTM pharmacist documents that a patient is non-adherent to a statin due to cost concerns and recommends a generic alternative. Which documentation element is most essential to record next?
- The patient's dietary habits and exercise frequency
- The prescriber contacted, date of contact, and outcome of the recommendation (Correct answer)
- The retail price of the branded statin at three local pharmacies
- The patient's credit score or financial assistance eligibility
Correct answer: The prescriber contacted, date of contact, and outcome of the recommendation
Closing the loop by documenting prescriber notification, the date, and the outcome of the therapeutic recommendation is essential to demonstrate that the identified DTP was addressed.
Question 5: Under CMS MTM program standards, which of the following patients would MOST likely meet eligibility criteria for enrollment?
- A 45-year-old with a single chronic condition taking one medication
- A 68-year-old Medicare Part D enrollee with diabetes, heart failure, and COPD taking 9 chronic medications (Correct answer)
- A 72-year-old taking two OTC supplements with no prescription drug coverage
- A 55-year-old with no chronic conditions taking antibiotics for an acute infection
Correct answer: A 68-year-old Medicare Part D enrollee with diabetes, heart failure, and COPD taking 9 chronic medications
CMS MTM eligibility typically requires multiple chronic conditions, multiple Part D medications, and likelihood of incurring high annual drug costs, which the 68-year-old clearly meets.
Question 6: Which documentation practice BEST demonstrates that a pharmacist resolved a potential adverse drug reaction identified during an MTM encounter?
- Noting the drug reaction in the patient's allergy field only
- Documenting the identified reaction, interventions taken, patient education provided, and monitoring plan established (Correct answer)
- Filing a MedWatch report without updating the patient record
- Removing the offending drug from the medication list without clinical notation
Correct answer: Documenting the identified reaction, interventions taken, patient education provided, and monitoring plan established
Comprehensive documentation of the identified reaction, all interventions, education given, and the follow-up monitoring plan demonstrates complete resolution of the drug therapy problem.
Question 7: A pharmacist working in a collaborative practice agreement (CPA) that allows medication adjustments must document which of the following to remain compliant with both state law and MTM standards?
- Only the final medication change, not the clinical rationale
- The CPA authority relied upon, clinical assessment, medication change made, and monitoring parameters (Correct answer)
- The physician's signature obtained retroactively within 30 days
- The pharmacist's personal opinion about the prescriber's original therapy choice
Correct answer: The CPA authority relied upon, clinical assessment, medication change made, and monitoring parameters
CPA-based medication adjustments require documentation of the legal authority (the CPA), the clinical basis for the change, what was changed, and how the outcome will be monitored.
MTM Documentation Standards & Regulatory Compliance 5
A Medicare Part D MTM program must, at minimum, offer a CMR to eligible beneficiaries how frequently?